Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 19, 2001

View Archived Issues

Bayer and CuraGen establish two collaborative agreements

Bioniche's MCC technology approved for prostate cancer clinical trials

Study of RSR-13 in combination with chemotherapy commences

Amylin reports company update and projections

Aphton to commence study of GnRH pharmaccine in combination with Taxotere

First once-monthly injectable contraceptive now available in the U.S.

World's first diagnostic agent for Parkinson's disease reaches market in Europe

Aventis Pasteur launches Hexavac, a significant advance in childhood vaccination

Worldwide licensing arrangement announced for TZT-1027

YM-905 enters late-stage clinical development overseas

Novogen receives grant for development of antiinflammatory drug

Traditional Chinese medicine has beneficial effects on body fat and triglycerides in animal model

Ligand's Ontak enters phase II for CLL

Halofuginone affects critical steps in the angiogenic process

Patient enrollment in OCTAVE hypertension trial nears completion

Phase II trials of ADL-8-2698 in opioid-induced bowel dysfunction successfully completed

Allergan obtains rights to compound for PDT of age-related macular degeneration

Combinations of lipopeptides and other antifungal agents reported to be synergistic

Neurochem cleared to advance Fibrillex to phase II/III clinical trials in the U.K.

Novel combination therapies useful for weight gain associated with antipsychotic drugs

Use of rhIL-11 for the treatment of hemorrhagic shock described by Genetics Institute

New series of 5-HT7 antagonists designed by the former SB

Inhibitors of NOS and their therapeutic use claimed in recent patents by AstraZeneca

Clinical evaluation of FKK-138 following single bolus doses

Antitumor compounds active against solid tumors and leukemias in the ADIR pipeline

Japanese team discloses new aldose reductase inhibitors

Quinazoline ACAT inhibitors and their use in lipid disorders

Antifungal antibiotic isolated from Penicillium sp. at Takara Shuzo

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...